Berberine is a plant compound found in barberry, goldenseal, and several other herbs used in traditional medicine. Some human studies suggest it can improve blood sugar measurements in people with type 2 diabetes. Those results are more useful than the animal experiment behind this article's original 2006 news report, but they still leave questions about long-term benefit, product quality, and safety.
What the original research tested
The 2006 paper studied diabetic mice, rats fed a high-fat diet, and laboratory cell lines. Berberine improved glucose tolerance in the mice and some metabolic measures in the rats. It also changed activity of a cell energy sensor called AMPK. The original study is Berberine, a natural plant product, activates AMP-activated protein kinase. Animal and cell results can suggest how a treatment might work. They cannot establish a useful dose or lasting benefit for a person with diabetes.
What happened in human trials?
A small 2008 pilot trial randomly assigned 36 adults with newly diagnosed type 2 diabetes to berberine or metformin for three months. In the berberine group, average HbA1c, a measure of blood sugar over roughly three months, fell from about 9.5% to 7.5%. The researchers reported a similar glucose-lowering effect in the comparison group. A second, nonrandomized part of the study added berberine to treatment for 48 adults whose diabetes was poorly controlled. Its before-and-after change cannot show what berberine alone caused. Across the study, 20 participants reported temporary digestive side effects. The paper is Efficacy of berberine in patients with type 2 diabetes mellitus.
A larger trial conducted at 20 centers in China compared berberine, probiotics, their combination, and placebo in adults with newly diagnosed type 2 diabetes. HbA1c fell more in the berberine groups over the short study period than in the comparison groups (PREMOTE randomized trial). This strengthens the case for a real effect on a blood marker, but it does not tell us whether taking berberine prevents heart attacks, kidney disease, or other long-term diabetes complications.
What the evidence does not establish
The old article treated lower body weight in rodents as proof that berberine could treat obesity in people. Weight loss needs to be measured in human trials. A six-month randomized study in people with obesity and fatty liver disease found no reduction in abdominal fat or liver fat compared with placebo, although some blood markers changed (Berberine and adiposity randomized trial). Formulations and participants differ across studies, so this does not erase the diabetes findings. It does rule out a sweeping claim that berberine reliably causes weight loss.
Berberine may interact with medicines and can cause nausea, diarrhea, bloating, or constipation. The US National Center for Complementary and Integrative Health advises against its use during pregnancy or breastfeeding and in infants. Anyone considering it while taking glucose-lowering medicine should discuss monitoring and interactions with a clinician. The useful takeaway is an emerging plant-based option with measurable short-term effects in some studies, rather than a proven replacement for diabetes care.
